Novel oral anticoagulant vs. warfarin in elderly atrial fibrillation patients with normal, mid ‐range, and reduced left ventricular ejection fraction

AbstractAimsPatients with concomitant atrial fibrillation (AF) and reduced left ventricular ejection fraction (LVEF) have poor prognosis. Outcomes of novel oral anticoagulant (NOAC) in elderly AF patients with normal, mid ‐range, and reduced LVEF were investigated.Methods and resultsData were retrieved from Chang Gung Research Database during 2010 –2017 for patients with AF. We excluded patients with venous thromboembolism within 6 months, total knee/hip replacement and heart valve replacement within 6 months, end‐stage renal disease, stroke/systemic embolism (SE)/death within 7 days, age
Source: ESC Heart Failure - Category: Cardiology Authors: Tags: Original Research Article Source Type: research

Related Links:

Source: Digestive Diseases and Sciences - Category: Gastroenterology Source Type: research
AbstractBackgroundDieulafoy ’s lesion (DL) is a rare but increasingly recognized cause of severe upper GI hemorrhage (SUGIH). There is little consensus regarding the endoscopic approach to management of bleeding from DL.AimsOur purposes were to compare 30-day outcomes of patients with SUGIH from DL with Doppler endoscopic probe (DEP) monitoring of blood flow and guided treatment versus standard visually guided hemostasis (VG).MethodsEighty-two consecutive DL patients with SUGIH were identified in a large CURE Hemostasis database from previous prospective cohort studies and two recent RCTs at two university-based medi...
Source: Digestive Diseases and Sciences - Category: Gastroenterology Source Type: research
Refresh for latest…: Warner Bros/Legendary’s Dune has surpassed expectations, harvesting $36.8M at the international box office from...
Source: Reuters: Health - Category: Consumer Health News Source Type: news
A SMALL degree of cognitive decline is expected of stroke sufferers after an incident, but the disruption that COVID-19 has inflicted on health services has left thousands of stroke patients suffering severe complications, including disability. One modifiable lifestyle habit could hike the chances of succumbing to a stroke.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
In conclusion, inhibiting the lysosomal oxidation of LDL in atherosclerotic lesions by antioxidants targeted at lysosomes causes the regression of atherosclerosis and improves liver and muscle characteristics in mice and might be a promising novel therapy for atherosclerosis in patients. NANOG Expression versus Cellular Senescence https://www.fightaging.org/archives/2021/09/nanog-expression-versus-cellular-senescence/ Are there many strategies that can reverse cellular senescence? There are certainly strategies that can lower levels of cellular senescence over time, both in cell cultures and in living an...
Source: Fight Aging! - Category: Research Authors: Tags: Newsletters Source Type: blogs
Contributors : Lingfang Zhuang ; Kangni Jia ; Zhigang Li ; Jiaxin Zhao ; Jian Hu ; Hang Zhang ; Qin Fan ; Chunkai Huang ; Hongyang Xie ; Lin Lu ; Weifeng Shen ; Guang Ning ; Jiqiu Wang ; Kang Chen ; Xiaoxiang YanSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusHere, we investigates the effects of dual-specificity tyrosine-regulated kinase 1B (DYRK1B) on mitochondrial bioenergetics, cardiac hypertrophy, and heart failure.We engineered DYRK1B transgenic and the effects of DYRK1B and its downstream mediators were subsequently elucidated using RNA-seq analysis. In this dataset, we inquire ...
Source: GEO: Gene Expression Omnibus - Category: Genetics & Stem Cells Tags: Expression profiling by high throughput sequencing Mus musculus Source Type: research
Contributors : Jette Lengefeld ; Chia-Wei Cheng ; Pema Maretich ; Marguerite Blair ; Hannah Hagen ; Melanie R McReynolds ; Emily Sullivan ; Kyra Majors ; Christina Roberts ; Joon H Kang ; Joachim D Steiner ; Teemu P Miettinen ; Scott R Manalis ; Adam Antebi ; Sean J Morrison ; Jacqueline A Lees ; Laurie A Boyer ; Ömer H Yilmaz ; Angelika AmonSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusStem cells are remarkably small in size. Human hematopoietic stem cells (HSCs) measure a mere 7  μm in diameter. Whether small size is important for stem cell function is unknown. We fin...
Source: GEO: Gene Expression Omnibus - Category: Genetics & Stem Cells Tags: Expression profiling by high throughput sequencing Mus musculus Source Type: research
Contributors : Jette Lengefeld ; Chia-Wei Cheng ; Pema Maretich ; Marguerite Blair ; Hannah Hagen ; Melanie R McReynolds ; Emily Sullivan ; Kyra Majors ; Christina Roberts ; Joon H Kang ; Joachim D Steiner ; Teemu P Miettinen ; Scott R Manalis ; Adam Antebi ; Sean J Morrison ; Jacqueline A Lees ; Laurie A Boyer ; Ömer H Yilmaz ; Angelika AmonSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusStem cells are remarkably small in size. Human hematopoietic stem cells (HSCs) measure a mere 7  μm in diameter. Whether small size is important for stem cell function is unknown. We fin...
Source: GEO: Gene Expression Omnibus - Category: Genetics & Stem Cells Tags: Expression profiling by high throughput sequencing Mus musculus Source Type: research
Malignant hyperthermia (MH) and exertional rhabdomyolysis (ERM) have long been considered as episodic phenotypes occurring in healthy individuals with RYR1 mutations in response to external triggers. Recent studies have shown evidence for continuous neuromuscular and multisystem features in these patients. There is a histopathological overlap with MH/ERM and myopathies, and patients with MH-associated RYR1 mutations can present with prominent axial weakness later in life. Animal studies have shown bleeding disorders and an immunological gain of function due to MH/ERM related RYR1 mutations.
Source: Neuromuscular Disorders - Category: Neurology Authors: Source Type: research
Semin Thromb Hemost DOI: 10.1055/s-0037-1615261This is an observational study to investigate the efficacy and safety of nonvitamin K antagonist oral anticoagulants (NOACs) in atrial fibrillation (AF) patients with bioprosthetic valves or prior surgical valve repair in clinical practice. A total of 122 patients (mean age: 74.1 ± 13.2; 54 females) with bioprosthetic heart valve or surgical valve repair and AF treated with NOACs were included in the analysis. The mean CHA2DS2-VASc (Congestive heart failure, Hypertension, Age>75 years, Diabetes mellitus, prior Stroke or transient ischemic attack, Vascul...
Source: Seminars in Thrombosis and Hemostasis - Category: Hematology Authors: Tags: Original Article Source Type: research
More News: Atrial Fibrillation | Bleeding | Cardiology | Chia | Coumadin | Databases & Libraries | Heart | Heart Failure | Heart Valve Disease | Heart Valve Surgery | Heart Valves | Ischemic Stroke | Stroke | Thrombosis | Warfarin